In the above article [Dvořák Z, Li H, and Mani S (2023) Drug Metab Dispos, 51(2): 219-227, DOI: https://doi.org/10.1124/dmd.122.000860], was published with three errors introduced by the compositor during the proofing process. These errors do not affect the conclusions of the paper. The corrected text is provided below.
1) Page 221, right column: “Field (49, 111) has discovered complementary host targets of IPA, which further asserts the premise that IPA inhibits inflammation” should have read “IPA has several complementary host targets, which further asserts the premise that IPA inhibits inflammation (Alexeev et al., 2021; Sári et al., 2020)”.
2) Page 222, right column: “However, a dietary microbial metabolite of chlorophyl A, phytol, and phytol’s, phytanic and pristanic acids are ligands of RXR and one heterodimeric partner, PPARα and PPARγ (Bobe et al., 2020)” should have read “However, a dietary microbial metabolite of chlorophyl A, phytol, and its metabolites, phytanic and pristanic acids, are ligands of RXR and one heterodimeric partner, PPARα and PPARγ (Bobe et al., 2020)”.
3) Page 224, left column: “Richard Okita Early Career Award in DMD” should have read “Richard Okita Early Career Award in Drug Metabolism and Disposition”.
The PDF and HTML versions of the article have been corrected.
The compositor apologizes for any inconvenience caused by these errors.